What Is Vitiligo? PDF Print E-mail
Wednesday, 04 November 2009 19:37
According to the MayoClinic Staff, Vitiligo (vit-ih-LI-go) is a condition in which your skin loses melanin, the pigment that determines the color of your skin, hair and eyes. Vitiligo occurs when the cells that produce melanin die or no longer form melanin, causing slowly enlarging white patches of irregular shapes to appear on your skin. Exactly why this occurs isn't known.

Vitiligo affects all races, but may be more noticeable and disfiguring in people with darker skin. Vitiligo usually starts as small areas of pigment loss that spread with time. These changes in your skin can result in stress and worries about your appearance. Like Scleroderma, there is no cure for vitiligo.

The goal of treatment is to stop or slow the progression of pigment loss and, if you desire, attempt to return some color to your skin.

Although any part of your body may be affected by Vitiligo, depigmentation usually develops first on sun-exposed areas of your skin, such as your hands, feet, arms, face and lips. Although it can start at any age, Vitiligo often first appears between the ages of 10 and 30.

The natural course of Vitiligo is difficult to predict. Sometimes the patches stop forming without treatment. But, in most cases, pigment loss spreads and can eventually involve most of the surface of your skin.

taken from http://www.flickr.com/photos/40097140@N02/3798426328/ via creative commonsDoctors and scientists have theories as to what causes Vitiligo. It may be due to an immune system disorder. Heredity may be a factor because there's an increased incidence of Vitiligo in some families. Some people have reported a single event, such as sunburn or emotional distress, that triggered the condition. However, none of these theories has been proven as a definite cause of Vitiligo.

Vitiligo is the most likely diagnosis in cases in which there is a progressive depigmentation leading to symmetrically distributed, chalk-white macules on the face, neck, scalp, mucous membranes, or periorificial areas, and not accompanied by any other symptom. This is essentially what differentiates Vitiligo from Scleroderma.

Diffuse scleroderma may result in areas of skin hypopigmentation. However, systemic signs of Scleroderma include essential vasomotor disturbances, such as Raynaud's phenomenon, fibrosis, and abnormalities of the lungs, kidneys, digestive system, and heart.

For more information on Vitiligo, you're welcome to view the MayoClinic's full article here, or visit the Vitiligo Foundation here. The International Scleroderma Network has some excellent links to additional resources on Vitiligo, such as diagnoses, personal stories and more. Similarly, there are many research papers on Vitiligo, one of which you can read here.
 
More articles :

» Second Systemic Sclerosis World Congress a Success

Great success for the second Systemic Sclerosis World Congress that was held in February at the Palacio de Congresos de Madrid.After the positive experience of 2010 in Florence, organised the second edition the congress, on behalf of World...

» HSCT Benefits In Early Diffuse Cutaneous Systemic Sclerosis

Initial results from an international, investigator-initiated, open label phase 3 trial, presented at EULAR 2012, indicate that haematopoietic stem cell transplantation (HSCT) results in better long-term survival than conventional treatment for...

» Understanding Autoimmune Diseases

When an intruder invades your body – like a cold virus or bacteria on a thorn that pricks your skin – your protects you. It tries to identify, kill, and eliminate the invaders that might hurt you. But sometimes problems with your immune system...

» Silicone and Scleroderma Revisited

Silicone, a synthetic polymer considered to be a biologically inert substance, is used in a multitude of medical products, the most publicly recognized of which are breast implants. Silicone breast implants have been in use since the early 1960s for...

» Prevention Of Vascular Damage In Scleroderma With Angiotensin-converting Enzyme (ACE) Inhibition

Great strides have been made in identifying and managing the organ-based complications of  systemic sclerosis (SSc). There is no room for the nihilism towards treating this disease that used to be so prevalent. However, there is still...

» Coping with Autoimmune Diseases from a Patient’s Perspective

Offering the last presentation of the Caribbean Autoimmune Diseases Summit, Mrs. Virginia Ladd shared some great insight and tips for coping with your autoimmune disease, however from a patient’s perspective.She started off by noting as patients,...

Add comment

Do feel free to leave your comments, as they would add value and knowledge to the community. However, please refrain from making any disparaging, uninformed, or unrelated comments. Thanks :)

Security code
Refresh